Literature DB >> 9785004

Automated in situ hybridization: diagnostic and research applications.

P Capodieci1, C Magi-Galluzzi, G Moreira, R Zeheb, M Loda.   

Abstract

Although in situ hybridization has been in use for almost 30 years, its technically demanding nature, the requirements for optimal tissue fixation and preservation, and the turnaround time for the experiments have prevented this technique from becoming widely used in the surgical pathology setting. The use of nonisotopic reporter molecules, the possibility of performing hybridization on archival material, and very recently, automation of the procedure have brought in situ hybridization to the forefront of diagnostic and experimental pathology. We describe our experience with nonradioactive, automated in situ hybridization, compare the technique with traditional manual procedures, and briefly outline its potential applications in diagnostic pathology and in the research setting.

Mesh:

Substances:

Year:  1998        PMID: 9785004     DOI: 10.1097/00019606-199804000-00002

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  3 in total

1.  Localization of keratin mRNA and collagen I mRNA in gastric cancer by in situ hybridization and hybridization electron microscopy.

Authors:  Chang-Qing Su; Hong Qiu; Yan Zhang
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution.

Authors:  Richard J Byers; Dolores Di Vizio; Fionnuala O'connell; Eleni Tholouli; Richard M Levenson; Kirk Gossage; Kirk Gossard; David Twomey; Yu Yang; Elisa Benedettini; Joshua Rose; Keith L Ligon; Stephen P Finn; Todd R Golub; Massimo Loda
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

3.  Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome.

Authors:  Marta Sanchez-Carbayo; Paola Capodieci; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.